Crucell: General Meeting 10 Jan 2006

Home | Contact Us | Search | Site Map

About Us

	Crucell at a Glance
	Our History
	Mission & Strategy
	Corporate Values
	Our Commitment to CSR
	Crucell Worldwide
	Management
	Corporate Governance
	Compliance
	Management Board
	Supervisory Board
	Articles of Association
	Code of Conduct
	Shareholder Meetings
	AGM 30 May 2008
	AGM 1 June 2007
	AGM 2 June 2006
	GM 10 January 2006
	AGM 2 June 2005
	Whistleblower Form

Crucell convened a General Meeting of Shareholders on January 10, 2005, at which the exchange offer for Berna Biotech A.G. (Swiss Exchange: BBIN) was approved in accordance with Section 2:107a of the Dutch Civil Code.

In addition, Messrs. Dominik Koechlin, Jürg Witmer and Claude Thomann were appointed as members of the Supervisory Board of Crucell upon the exchange offer becoming or being declared unconditional.

Further, approval was received for the dismissal of Crucell’s external auditor, Ernst & Young, following many years of good cooperation. The Supervisory Board’s proposal was based on the advice of the Audit Committee and the Board of Management with regard to the desirability for a systematic rotation of the external auditor. Deloitte was subsequently appointed as Ernst & Young’s successor.

The General Meeting of Shareholders was held in Dutch with an English translation available. Click on the link below to access both Dutch and English versions.

Video Webcast

(To view the video webcast, Java Runtime is required.)

Documents relevant to the General Meeting of Shareholders are listed below.

English Versions:

Shareholders Circular

Convocation GM 10 January 2006

Agenda and Explanatory Notes GM 10 January 2006

Nederlandse versies:

Uitnodiging AVA 10 januari 2006

Agenda AVA 10 januari 2006

(All documents are PDF files. For PDF files, Adobe Acrobat is required.)